Shares of Harvard Bioscience Inc. (NASDAQ:HBIO) saw unusually-strong trading volume on Thursday . Approximately 161,338 shares traded hands during trading, an increase of 115% from the previous session’s volume of 75,177 shares.The stock last traded at $2.95 and had previously closed at $2.99.

Separately, Zacks Investment Research cut shares of Harvard Bioscience from a “hold” rating to a “sell” rating in a research note on Thursday, May 5th.

The company’s market cap is $97.26 million. The company’s 50 day moving average is $3.09 and its 200-day moving average is $3.00.

Harvard Bioscience (NASDAQ:HBIO) last announced its earnings results on Thursday, July 28th. The company reported $0.03 EPS for the quarter, hitting the consensus estimate of $0.03. The company had revenue of $26.10 million for the quarter, compared to the consensus estimate of $26.60 million. Equities analysts anticipate that Harvard Bioscience Inc. will post $0.17 EPS for the current fiscal year.

Harvard Bioscience, Inc is a developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments. The Company’s products are used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories across the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.